Endometrial stromal sarcoma in a large fibroid uterus presenting with sepsis-like picture, extensive pelvic thrombosis and severe menorrhagia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262135Keywords:
Endometrial stromal sarcoma, Uterine sarcoma, Abnormal uterine bleeding, Pelvic thrombosis, Diagnostic delayAbstract
This case report aims to demonstrate the diagnostic challenges of uterine sarcomas, presenting with presumed benign symptoms. Missed clinical clues and consequently a delayed diagnosis demonstrates the importance of considering uterine sarcomas as a differential, particularly in premenopausal women. This case report describes the case of a woman in her early 40s, who presented with symptoms of fibroids, before receiving an incidental diagnosis of endometrial stromal sarcoma, almost a year after her initial hospital presentation. The patient had an extensive investigative period, repeatedly returning to hospital with symptoms including lower abdominal pain and heavy vaginal bleeding, and imaging and biopsies not pointing clinicians to the diagnosis. Many findings and reports presented clues which should have pointed towards an alternative diagnosis-raised LDH, extensive pelvic thrombosis, the presence of a pelvic lymph node, and lack of response to treatment-none of which were considered as consequences of a uterine sarcoma. Diagnostic interpretation was complicated by factors such as a raised BMI, continuous bleeding, and the need for anticoagulation, making the final diagnosis hard to reach. This case demonstrates the criticalness of considering uterine sarcomas as a mimic for benign gynaecological conditions and symptoms. Timely recognition and early consideration is critical to improve outcomes, and uterine sarcomas should always be discussed as a potential diagnosis, especially in premenopausal women.
References
Zhu M, Chen S. Clinical features of uterine sarcomas presenting mainly with uterine masses: a retrospective study. BMC Womens Health. 2023;23(1):674.
Mbatani N, Olawaiye AB, Prat J. Uterine sarcomas. International Journal of Gynecology & Obstetrics. 2018;143:51-8.
Benson C, Miah AB. Uterine sarcoma-current perspectives. Int J Women’s Health. 2017;9:597-606.
Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagnostic and Interventional Radiology. 2015;21(1):4-9.
Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol. 2011;25(6):681-9.
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynecol Obstet. 2020;149(1):3-9.
Mallmann P. Uterine sarcoma-difficult to diagnose, hard to treat. Oncol Res Treat. 2018;41(11):674.
Kho RM, Desai VB, Schwartz PE, Wright JD, Gross CP, Hutchison LM, et al. Endometrial sampling for preoperative diagnosis of uterine leiomyosarcoma. J Minimally Invasive Gynecol. 2022;29(1):119-27.
Francis M, Dennis NL, Hirschowitz L, Grimer R, Poole J, Lawrence G, et al. Incidence and survival of gynecologic sarcomas in England. Int J Gynecol Cancer. 2015;25(5):850-7.
National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: assessment and management (NG88). 2018. Available at: https://www.nice.org.uk/guidance/ng88. Accessed on 11 April 2026.
Choi JI, Lee HJ, Shin YJ, Lim HW, Lee HN, Kim MJ. Rapid enlargement of endometrial stromal sarcoma after uterine fibroid embolization for presumed adenomyosis: a case report and literature review. Europ J Gynaecolog Oncol. 2016;37(6):876-81.
Kao MJ, Roy M, Harter J, Spencer RJ. Uterine sarcoma presenting with sepsis from Clostridium perfringens endometritis in a postmenopausal woman. Case Rep Obstet Gynecol. 2018;2018:8217296.
Tiwari PR, Lele A, Vishnoi R, Jain N. Endometrial stromal sarcoma of the uterus with malignant thrombosis of the iliac and femoral veins: case report and review of literature. J Biomed Graph Comput. 2012;2(2):1.
Kundu S, Karakas H, Hertel H, Hillemanns P, Staboulidou I, Schippert C, et al. Peri- and postoperative management and outcomes of morbidly obese patients (BMI>40 kg/m²) with gynaecological disease. Arch Gynecol Obstet. 2018;297(5):1221-33.
Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, et al. Comprehensive review of uterine leiomyosarcoma: pathogenesis, diagnosis, prognosis, and targeted therapy. Cells. 2022;13(13):1106.
Sousou TC, Khorana AA. New insights into cancer-associated thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29(3):316-20.